Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
YETI Holdings
YETI
5
Teradata Corp
TDC
US Stock MarketDetailed Quotes
CYTK Cytokinetics
- 33.040
- -0.930-2.74%
Close May 7 16:00 ET
- 32.870
- -0.170-0.51%
Post 20:01 ET
3.95BMarket Cap-6.25P/E (TTM)
35.360High32.300Low3.79MVolume35.340Open33.970Pre Close126.37MTurnover3.19%Turnover RatioLossP/E (Static)119.43MShares63.45752wk High-14.81P/B3.93BFloat Cap32.30052wk Low--Dividend TTM118.86MShs Float110.250Historical High--Div YieldTTM9.01%Amplitude3.050Historical Low33.344Avg Price1Lot Size
Cytokinetics Key Stats
Quarterly+Annual
YOY
| (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -1.63%-131.62M | 4.45%-395.89M | 11.44%-65.57M | -5.50%-101.5M | 18.47%-99.31M | -5.91%-129.51M | -38.33%-414.33M | 24.60%-74.04M | -14.48%-96.21M | -34.63%-121.81M |
| Net income from continuing operations | -18.97%-161.38M | -12.03%-589.53M | -9.59%-150.02M | -24.05%-160.55M | -11.41%-143.32M | -3.32%-135.64M | -35.30%-526.24M | 0.35%-136.9M | 9.06%-129.42M | -549.03%-128.64M |
| Operating gains losses | --400K | -3,740.00%-1.27M | ---1.17M | ---700K | ---- | ---- | -98.75%35K | --0 | --0 | --1K |
| Depreciation and amortization | -1.33%2.3M | -19.85%9.53M | -62.38%2.38M | 30.04%2.41M | 29.70%2.41M | 26.14%2.33M | 104.54%11.89M | 282.09%6.34M | 31.68%1.85M | 31.84%1.86M |
| Other non cash items | 10.37%8.71M | 108.92%51.88M | 294.81%15.28M | 97.87%22.09M | -36.49%6.61M | -28.88%7.89M | -56.95%24.83M | -209.01%-7.84M | -64.94%11.17M | 9.43%10.41M |
| Change In working capital | 79.76%-5.2M | 1,054.55%35.66M | -7.05%41.71M | 567.39%9.88M | 140.53%9.77M | -34.05%-25.7M | 112.50%3.09M | 166.50%44.88M | -87.38%1.48M | 74.30%-24.1M |
| -Change in receivables | 3,160.13%14.64M | -1,252.73%-15.37M | -1,449.18%-16.41M | 83.88%-244K | 3,871.43%834K | 152.27%449K | -102.00%-1.14M | -43.36%1.22M | -371.65%-1.51M | -99.49%21K |
| -Change in prepaid assets | 94.33%-376K | -252.76%-2.44M | -198.96%-8.44M | 1,208.48%4.48M | 244.39%8.16M | -307.50%-6.63M | 121.53%1.6M | 458.44%8.53M | 137.62%342K | 14.51%-5.65M |
| -Change in payables and accrued expense | -19.34%-18.94M | -28.79%9.7M | -59.88%15.98M | 34.10%7.23M | 115.00%2.36M | -0.08%-15.87M | -11.37%13.62M | 213.77%39.84M | -55.25%5.39M | -468.35%-15.75M |
| -Change in other current liabilities | 85.69%-522K | 21.75%-8.6M | 62.04%-1.79M | 42.46%-1.58M | 41.52%-1.59M | -342.06%-3.65M | -371.72%-10.99M | -1,106.41%-4.71M | -398.47%-2.74M | -85.22%-2.72M |
| -Change in other working capital | ---- | --52.37M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -1.63%-131.62M | 4.45%-395.89M | 11.44%-65.57M | -5.50%-101.5M | 18.47%-99.31M | -5.91%-129.51M | -38.33%-414.33M | 24.60%-74.04M | -14.48%-96.21M | -34.63%-121.81M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 224.61%105.96M | -331.18%-553.1M | 236.18%110.86M | -161.68%-45.05M | -893.33%-651.55M | -80.28%32.64M | 191.27%239.25M | -378.34%-81.41M | 124.98%73.04M | 25.83%82.13M |
| Net PPE purchase and sale | ---5.66M | -175.85%-3.91M | -1,575.32%-1.29M | -218.64%-701K | -167.09%-1.92M | --0 | 87.51%-1.42M | 97.60%-77K | 96.53%-220K | 16.34%-717K |
| Net investment purchase and sale | 241.96%111.62M | -328.19%-549.19M | 237.89%112.15M | -160.54%-44.35M | -884.15%-649.63M | -80.32%32.64M | 195.96%240.67M | -350.61%-81.33M | 125.61%73.26M | 25.29%82.85M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 224.61%105.96M | -331.18%-553.1M | 236.18%110.86M | -161.68%-45.05M | -893.33%-651.55M | -80.28%32.64M | 191.27%239.25M | -378.34%-81.41M | 124.98%73.04M | 25.83%82.13M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -95.42%4.75M | 320.49%930.61M | -98.59%2.38M | -93.68%3.43M | 14,895.63%821.01M | 1,546.16%103.79M | -57.12%221.32M | 464.83%168.8M | -86.06%54.22M | 60.28%5.48M |
| Net issuance payments of debt | -209.44%-2.88M | -1,020.98%-9.62M | -1,212.61%-2.91M | -1,233.64%-2.89M | -1,257.55%-2.88M | -350.24%-932K | -100.26%-858K | -111.43%-222K | -100.06%-217K | 20.60%-212K |
| Net common stock issuance | --0 | 330.39%706.84M | --0 | --0 | --613.2M | --93.64M | --164.23M | --162.92M | --1.31M | --0 |
| Proceeds from stock option exercised by employees | -74.09%7.65M | 187.21%53.02M | 6.21%6.48M | 102.27%6.32M | 87.88%10.69M | 732.59%29.53M | 5.22%18.46M | 69.57%6.1M | -49.51%3.12M | 54.41%5.69M |
| Net other financing activities | 99.93%-13K | 356.83%180.37M | ---1.18M | --0 | --200M | -75.42%-18.45M | -75.92%39.48M | --0 | --50M | --0 |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -95.42%4.75M | 320.49%930.61M | -98.59%2.38M | -93.68%3.43M | 14,895.63%821.01M | 1,546.16%103.79M | -57.12%221.32M | 464.83%168.8M | -86.06%54.22M | 60.28%5.48M |
| Net cash flow | ||||||||||
| Beginning cash position | -16.02%95.23M | 68.79%113.4M | -52.77%47.26M | 176.06%190.52M | 16.60%120.35M | 68.79%113.4M | -40.37%67.18M | -5.81%100.07M | -26.29%69.01M | -10.58%103.22M |
| Current changes in cash | -401.91%-20.91M | -139.74%-18.38M | 257.08%47.68M | -560.92%-143.13M | 305.10%70.15M | -80.78%6.93M | 201.66%46.24M | 134.19%13.35M | 146.32%31.05M | -56.95%-34.2M |
| Effect of exchange rate changes | -1,100.00%-270K | 1,145.00%209K | 1,560.00%292K | ---126K | --16K | --27K | ---20K | ---20K | --0 | --0 |
| End cash Position | -38.47%74.06M | -16.02%95.23M | -16.02%95.23M | -52.77%47.26M | 176.06%190.52M | 16.60%120.35M | 68.79%113.4M | 68.79%113.4M | -5.81%100.07M | -26.29%69.01M |
| Free cash flow | -6.00%-137.28M | 3.84%-399.8M | 9.79%-66.86M | -5.99%-102.2M | 17.38%-101.23M | -5.56%-129.51M | -33.75%-415.75M | 26.91%-74.11M | -6.70%-96.43M | -34.15%-122.52M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- |
Market Insights
Discussing
Berkshire 2025 highlights: Stepping aside as CEO, trade and market volatility
$Berkshire Hathaway-A (BRK.A.US)$ held its highly anticipated annual shareholders meeting Saturday. Here are some key takeaways from the eve
Buffettttttt
May 3 21:00
Berkshire's 2025 Annual Shareholders Meeting
Discussing
FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma
Moo Live
Mar 20 02:25
FOMC Press Conference, March 19, 2025
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now
